BP Heads Into Q2 Print on a 22% Monthly Surge

BP arrives at its August 4 second-quarter results riding one of the sharpest one-month rallies in its recent history — a 22% gain to $45.22 — and that price move is the central tension heading into Tuesday's release.

The lending market is entirely relaxed about the rally. Borrow availability is exceptionally loose at over 1,500% — meaning shares available to borrow dwarf those already lent out by a factor of fifteen — and the cost to borrow runs at just 0.43%. Short interest on US-listed shares has risen about 7% over the past week to roughly 11 million shares, but that move tells a less alarming story in context: it follows a sharp drop from around 16 million shares in early July, and the ORTEX short score sits at a mild 28.9, well below levels that would signal meaningful bearish conviction. The borrow market is not pricing in a squeeze, and shorts are not building an aggressive structural position. Options positioning has nudged slightly more defensive into the print — the put/call ratio ticked up to 0.44 on Friday, about 1.7 standard deviations above its 20-day average — but remains far below its 52-week high of 0.72, so hedging demand is elevated without being extreme.

The analyst community has been active and broadly constructive in the weeks before the print, but not uniformly so. Mizuho initiated with an Outperform rating and a $51 target on July 20, while Piper Sandler came in at Neutral with a $42 target three days later — a gap that captures the debate precisely. TD Cowen maintained a Hold and nudged its target to $41. Earlier upgrades from RBC Capital, UBS, and Argus Research through April and May added momentum to the bull case, which rests on BP's debt-reduction progress, capital discipline, and the potential for the stock to close its valuation discount to peers. The bear case focuses on the absence of share buybacks, elevated balance sheet leverage relative to Shell and TotalEnergies, and the sensitivity of the investment case to volatile crude prices. At a forward P/E near 9.6x and a price-to-book of 1.57, the valuation is not stretched in absolute terms — but BP now trades at $45.22 against an older analyst consensus mean target of roughly $37, a figure that almost certainly reflects stale models predating the recent surge and should not be read as a ceiling.